KIEV, Dec. 25 – The opportunity for foreign pharmaceutical producers to take part in medicine public procurement using budget funds directly, without mediators, is the key benefit of the transfer of public procurement to international organizations, Oleksandra Ustinova, a board member of the Anticorruption Action Center, told Interfax-Ukraine.

"The opportunity of direct participation of international pharmaceutical company without intermediaries is a key benefit of the transfer of procurement [to international organizations]. Companies will be able to sell their products not via distributors, as it happened in 90% of cases in Ukraine, but directly, even via the head offices, without participation of Ukrainian representative offices," she said.